Skip to main content
. 2017 May 18;9(14):677–688. doi: 10.4254/wjh.v9.i14.677

Table 2.

Baseline total patient number, number of male patients, mean age, body mass index and ethnicity for the 8 included studies

Ref. Patients
 Mean age BMI Ethnicity
Males Total (n) (yr) (kg/m2) Caucasian African American Asian
Apolinario et al[9] 40 63 41 (± 9.3)5 Information not provided Information not provided6
1Lagging et al[34] 169 2522 2529
IL28B rs12979860 CC 64 93 41.6 (± 10.1)5 25.1 (± 3.6)5
IL28B rs12979860 CT 77 123 41.9 (± 9.5)5 25.0 (± 3.5)5
IL28B rs12979860 TT 28 36 41.9 (± 11.4)5 25.0 (± 3.5)5
Diago et al[7] 77 137 42 (± 9.7)5 Information not provided Information not provided
Fattovich et al[21] 133 2263 46 (± 11)5 24.7 (± 3.8)5 226
Kurelac et al[33] 17 46 41.5 (± 12.4)5 23.7 (21.9-25)4 46
Darling et al[31] 176 272 48.4 (± 7.4)5 Information not provided 138 134
Darbala et al[32] 144 159 46.47 (± 8.83)5 30.18 (± 5.05)5 Information not provided7
Al-Ashgar et al[19] 41 64 38.7 (± 11.5)5 Information not provided Information not provided8
1

Study did not provide baseline characteristics for their entire population, but instead provided baseline demographics in accordance with IL-28 genotype (only baseline characteristics for rs12979860 are reported in the review, as these were representative for the study population);

2

253 was reported to be enrolled, however when adding the males and female patients, it sums to 252;

3

Only 226 out of 280 patients had serum available for iP-10 testing;

4

Median (25-75 percentiles);

5

Mean (SD);

6

51 patients from clinical trials had Spanish nationality;

7

Egyptian nationality;

8

Saudi nationality;

9

95% of the original DITTO patient population were Caucasian. BMI: Body mass index.